sickle cell

Or blood cells may be examined for signs of sickle-cell anemia, leukemia, or other disorders.

People undergoing sickle cell crisis can experience extreme pain that is not always managed effectively.

This article describes an audit of pain management in sickle cell disease that was used to generate practice guidelines.

Sickle-cell anaemia is a common genetic condition due to a haemoglobin disorder.

Such screening techniques and early intervention therapies have sharply lowered the mortality rate in children with sickle cell disease.

Approximately 5% of the world's population are healthy carriers of a gene for sickle-cell disease or thalassaemia.

Patients with sickle cell disease or trait are particularly susceptible to glaucomatous optic nerve damage from even mildly elevated IOPs.

Babies with sickle cell disease typically do not exhibit symptoms until after 6 months of age.

You only get malaria protection. It's only when you inherit the mutation from both parents that you get sickle-cell anemia.

High risk conditions included asthma, sickle cell disease, HIV infection, and chronic cardiac disease, among others.

This condition leads to shortened red blood cell survival, and subsequent anaemia, often called sickle-cell anaemia.

Sickle cell disease is a blood disorder due to a single genetic mutation.

These disorders may include cystic fibrosis, hemophilia, sickle cell anemia, and many others.

In other studies, bone marrow transplants cure severe sickle cell disease in almost two hundred children.

Sickle cell disease is a disorder in which blood cells carry a mutation in hemoglobin.

Sickle-cell anemia is a blood disease that causes the cell to form a characteristic sickle-shape.

Millions of people around the world, most of them of African origin, suffer from sickle cell disease.

The team showed that children with the sickle-cell mutation had fewer parasites in their blood.

The sickle cell mutation apparently arose repeatedly in regions riddled with malaria in Africa and the Middle East.

To investigate BCL11A's therapeutic value, Orkin's team turned to a mouse model for sickle cell disease.

For instance, between 60 and 80 per cent of people with sickle cell anaemia, a genetic condition, resist malaria.

It's long been known, for example, that gene variations that protect some Africans from malaria make them vulnerable to sickle-cell anemia.

Sickle-cell disease can be managed by simple procedures including

Renaissance Of Sickle Cell Disease Research In The Genomic Era

Kidney disease in sickle cell anemia

BMC Cell Biology Sickle Cell Disease Association of America Sickle Cell Society